News
Cancer patient treated by L+M doctor free of tumors after receiving new drug
David Pierson had his hands full last week as he headed to an appointment with his urologist at Lawrence + Memorial Hospital.
A urothelial cancer patient for more than 20 years, Pierson’s options were few when Dr. Joseph Brito deemed him a candidate for Jelmyto, a new formulation of mitomycin, a chemotherapy drug used for decades in the treatment of various cancers, including those of the urinary tract and kidneys.
Approved by the U.S. Food and Drug Administration in 2020, Jelmyto had never been delivered to a patient in Connecticut. Pierson would be the first to receive it.
The timing was fortuitous.
Source: The Day